hemicholinium 3 has been researched along with oxidopamine in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (60.00) | 18.7374 |
1990's | 2 (20.00) | 18.2507 |
2000's | 2 (20.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Joyce, JN | 1 |
Beleslin, DB; Jovanović-Mićić, D; Nedelkovski, V; Samardzić, R; Strbac, M | 1 |
Beleslin, DB; Krstić, SK | 2 |
Landis, S; Leblanc, G | 1 |
Beleslin, DB; Jovanovic-Micic, D; Tomic-Beleslin, N | 1 |
Koley, BN; Koley, J; Saha, JK | 1 |
Beleslin, DB; Jovanović-Mićić, D; Samardzić, R | 1 |
Araki, T; Fujihara, K; Imai, Y; Itoyama, Y; Kato, H; Mizugaki, M; Tanji, H | 1 |
Gorman, L; Heidenreich, BA; Lee, JM; Mitrovic, I; Muma, NA; Napier, TC | 1 |
10 other study(ies) available for hemicholinium 3 and oxidopamine
Article | Year |
---|---|
Differential response of striatal dopamine and muscarinic cholinergic receptor subtypes to the loss of dopamine. I. Effects of intranigral or intracerebroventricular 6-hydroxydopamine lesions of the mesostriatal dopamine system.
Topics: Animals; Autoradiography; Corpus Striatum; Dopamine; Hemicholinium 3; Injections, Intraventricular; Male; Mazindol; Oxidopamine; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Muscarinic; Substantia Nigra | 1991 |
Area postrema: cholinergic and noradrenergic regulation of emesis. A new concept.
Topics: (4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride; Animals; Brain Stem; Cats; Cerebral Ventricles; Choline; Emetics; Female; Hemicholinium 3; Hydroxydopamines; Male; Norepinephrine; Oxidopamine; Reserpine; Vomiting | 1989 |
Dimethylphenylpiperazinium-induced vomiting: nicotinic mediation in area postrema.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Cats; Cerebral Ventricles; Copper; Copper Sulfate; Dimethylphenylpiperazinium Iodide; Dopamine Antagonists; Female; Ganglionic Blockers; Hemicholinium 3; Histamine H1 Antagonists; Hydroxydopamines; Male; Oxidopamine; Parasympatholytics; Piperazines; Receptors, Nicotinic; Reserpine; Serotonin; Serotonin Antagonists; Vomiting | 1986 |
Nicotine-induced convulsions in cats and central nicotinic receptors.
Topics: 5,6-Dihydroxytryptamine; Animals; Brain; Cats; Dopamine Antagonists; Female; Ganglionic Blockers; Hemicholinium 3; Hydroxydopamines; Injections, Intraventricular; Male; Nicotine; Oxidopamine; Parasympatholytics; Receptors, Nicotinic; Reserpine; Seizures; Serotonin Antagonists; Sympatholytics | 1986 |
Development of choline acetyltransferase (CAT) in the sympathetic innervation of rat sweat glands.
Topics: Acetylcholine; Animals; Animals, Newborn; Choline; Choline O-Acetyltransferase; Hemicholinium 3; Histocytochemistry; Hydroxydopamines; Naphthylvinylpyridine; Oxidopamine; Rats; Sweat Glands; Sympathetic Nervous System | 1986 |
Nature of salivation produced by thyrotropin-releasing hormone (TRH).
Topics: 5,6-Dihydroxytryptamine; Animals; Atropine; Cats; Female; Hemicholinium 3; Hydroxydopamines; Male; Mecamylamine; Oxidopamine; Reserpine; Salivation; Thyrotropin-Releasing Hormone | 1987 |
Effects of nicotine on spontaneous contractions of isolated atria of toad (Bufo melanostictus).
Topics: Animals; Atropine; Bufonidae; Caffeine; Edetic Acid; Hemicholinium 3; Hexamethonium Compounds; Hydroxydopamines; In Vitro Techniques; Myocardial Contraction; Nicotine; Oxidopamine; Physostigmine; Tyramine; Verapamil | 1987 |
The role of alpha-adrenergic mechanisms within the area postrema in dopamine-induced emesis.
Topics: Adrenergic alpha-Antagonists; alpha-Methyltyrosine; Animals; Atropine; Cats; Cerebral Ventricles; Dioxanes; Disease Models, Animal; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Female; Hemicholinium 3; Idazoxan; Injections, Intraventricular; Male; Mecamylamine; Methyltyrosines; Methysergide; Naloxone; Oxidopamine; Prazosin; Reserpine; Tolazoline; Tyrosine 3-Monooxygenase; Vomiting; Yohimbine | 1995 |
Sequential changes of cholinergic and dopaminergic receptors in brains after 6-hydroxydopamine lesions of the medial forebrain bundle in rats.
Topics: Animals; Autoradiography; Choline; Cholinergic Agents; Corpus Striatum; Dopamine Antagonists; Hemicholinium 3; Male; Medial Forebrain Bundle; Muscarinic Agonists; Nerve Degeneration; Oxidopamine; Quinuclidinyl Benzilate; Raclopride; Radioligand Assay; Rats; Rats, Wistar; Receptors, Cholinergic; Receptors, Dopamine D2; Substantia Nigra; Sympatholytics; Tritium | 2000 |
6-hydroxydopamine-induced lesions of dopaminergic neurons alter the function of postsynaptic cholinergic neurons without changing cytoskeletal proteins.
Topics: Amygdala; Animals; Brain; Cholinergic Agents; Cytoskeletal Proteins; Dopamine; Frontal Lobe; Hemicholinium 3; Male; Microinjections; Neurons; Organ Specificity; Oxidopamine; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Synapses | 2001 |